Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article - Enabling Technologies
  • Published:

Original Article – Enabling Technologies

Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells

Gene Therapy volume 22, pages 685–695 (2015)Cite this article

Subjects

Abstract

This article describes a novel method merging the cloning of viral vector producer cells with vector titer screening, allowing for screening 200–500 clones in 2 weeks. It makes use of a GFP separated into two fragments, S10 and S11 (Split GFP), fluorescing only upon transcomplementation. Producer cells carrying a S11 viral transgene are cloned in 96-well plates and co-cultured with target cells stably expressing S10. During the period of clone expansion, S11 viruses infect S10 target cells reconstituting the GFP signal. Transcomplemented fluorescence data provide direct estimation of the clone’s productivity and can be analyzed in terms of density distribution, offering valuable information on the average productivity of the cell population and allowing the identification of high-producing clones. The method was validated by establishing a retrovirus producer from a nude cell line, in <3 months, inserting three vector constructs without clone selection or screening in between. Clones producing up to 108 infectious particles per ml were obtained, delivering optimal ratios of infectious-to-total particles (1 to 5). The method was additionally used to evaluate the production performance of HEK 293 and HEK 293T cell lines demonstrating that the latter sustains increased titers. Finally, it was used to study genetic manipulation of glutathione metabolism in retrovirus production showing that changing cell metabolism steers higher vector expression with titer increases of more than one order of magnitude.This method is a valuable tool not only for cell line development but also for genetic manipulation of viral vector and/or producer cells contributing to advancing the field of viral gene therapy.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6

Similar content being viewed by others

References

  1. Edelstine M . The Journal of Gene Medicine Clinical Trial Site. http://www.wiley.com/legacy/wileychi/genmed/clinical.

  2. Moran N . First gene therapy nears landmark European market authorization. Nat Biotechnol 2012; 30: 807–809.

    Article  CAS  PubMed  Google Scholar 

  3. Sheridan C . Gene therapy finds its niche. Nat Biotechnol 2011; 29: 121–128.

    Article  CAS  PubMed  Google Scholar 

  4. Ikeda Y, Takeuchi Y, Martin F, Cosset FL, Mitrophanous K, Collins M . Continuous high-titer HIV-1 vector production. Nat Biotechnol 2003; 21: 569–572.

    Article  CAS  PubMed  Google Scholar 

  5. Stornaiuolo A, Piovani BM, Bossi S, Zucchelli E, Corna S, Salvatori F et al. RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy. Hum Gene Ther Methods 2013; 24: 228–240.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Coroadinha AS, Gama-Norton L, Amaral AI, Hauser H, Alves PM, Cruz PE . Production of retroviral vectors: review. Curr Gene Ther 2010; 10: 456–473.

    Article  CAS  PubMed  Google Scholar 

  7. Schweizer M, Merten OW . Large-scale production means for the manufacturing of lentiviral vectors. Curr Gene Ther 2010; 10: 474–486.

    Article  CAS  PubMed  Google Scholar 

  8. Seymour LW, Thrasher AJ . Gene therapy matures in the clinic. Nat Biotechnol 2012; 30: 588–593.

    Article  CAS  PubMed  Google Scholar 

  9. Carrondo M, Panet A, Wirth D, Coroadinha AS, Cruz P, Falk H et al. Integrated strategy for the production of therapeutic retroviral vectors. Hum Gene Ther 2011; 22: 370–379.

    Article  CAS  PubMed  Google Scholar 

  10. Coroadinha AS, Schucht R, Gama-Norton L, Wirth D, Hauser H, Carrondo MJ . The use of recombinase mediated cassette exchange in retroviral vector producer cell lines: predictability and efficiency by transgene exchange. J Biotechnol 2006; 124: 457–468.

    Article  CAS  PubMed  Google Scholar 

  11. Gama-Norton L, Herrmann S, Schucht R, Coroadinha AS, Low R, Alves PM et al. Retroviral vector performance in defined chromosomal Loci of modular packaging cell lines. Hum Gene Ther 2010; 21: 979–991.

    Article  CAS  PubMed  Google Scholar 

  12. Hennig K, Raasch L, Kolbe C, Weidner S, Leisegang M, Uckert W et al. HEK293-based production platform for gamma-retroviral (self-inactivating) vectors: application for safe and efficient transfer of COL7A1 cDNA. Hum Gene Ther Clin Dev 2014; 25: 218–228.

    Article  CAS  PubMed  Google Scholar 

  13. Loew R, Meyer Y, Kuehlcke K, Gama-Norton L, Wirth D, Hauser H et al. A new PG13-based packaging cell line for stable production of clinical-grade self-inactivating gamma-retroviral vectors using targeted integration. Gene Ther 2010; 17: 272–280.

    Article  CAS  PubMed  Google Scholar 

  14. Schucht R, Coroadinha AS, Zanta-Boussif MA, Verhoeyen E, Carrondo MJ, Hauser H et al. A new generation of retroviral producer cells: predictable and stable virus production by Flp-mediated site-specific integration of retroviral vectors. Mol Ther 2006; 14: 285–292.

    Article  CAS  PubMed  Google Scholar 

  15. Cabantous S, Terwilliger TC, Waldo GS . Protein tagging and detection with engineered self-assembling fragments of green fluorescent protein. Nat Biotechnol 2005; 23: 102–107.

    Article  CAS  PubMed  Google Scholar 

  16. Green BJ, Rasko JE . Rapid screening for high-titer retroviral packaging cell lines using an in situ fluorescence assay. Hum Gene Ther 2002; 13: 1005–1013.

    Article  CAS  PubMed  Google Scholar 

  17. Ou W, Marino MP, Lu C, Reiser J . Rapid titration of retroviral vectors using a beta-lactamase protein fragment complementation assay. Gene Ther 2012; 20: 43–50.

    Article  PubMed  Google Scholar 

  18. Carrondo MJ, Merten OW, Haury M, Alves PM, Coroadinha AS . Impact of retroviral vector components stoichiometry on packaging cell lines: effects on productivity and vector quality. Hum Gene Ther 2008; 19: 199–210.

    Article  CAS  PubMed  Google Scholar 

  19. Gama-Norton L, Botezatu L, Herrmann S, Schweizer M, Alves PM, Hauser H et al. Lentivirus production is influenced by SV40 large T-antigen and chromosomal integration of the vector in HEK293 cells. Hum Gene Ther 2011; 22: 1269–1279.

    Article  CAS  PubMed  Google Scholar 

  20. Rodrigues AF, Carrondo MJ, Alves PM, Coroadinha AS . Cellular targets for improved manufacturing of virus-based biopharmaceuticals in animal cells. Trends Biotechnol 2014; 32: 602–607.

    Article  CAS  PubMed  Google Scholar 

  21. Rodrigues AF, Formas-Oliveiras AS, Bandeira VS, Alves PM, Hu WS, Coroadinha AS . Metabolic pathways recruited in the production of a recombinant enveloped virus: mining targets for process and cell engineering. Metab Eng 2013; 20: 131–145.

    Article  CAS  PubMed  Google Scholar 

  22. Schambach A, Galla M, Maetzig T, Loew R, Baum C . Improving transcriptional termination of self-inactivating gamma-retroviral and lentiviral vectors. Mol Ther 2007; 15: 1167–1173.

    Article  CAS  PubMed  Google Scholar 

  23. Vu HN, Ramsey JD, Pack DW . Engineering of a stable retroviral gene delivery vector by directed evolution. Mol Ther 2008; 16: 308–314.

    Article  CAS  PubMed  Google Scholar 

  24. DuBridge R, Tang P, Hsia H, Leong P, Miller J, Calos M . Analysis of mutation in human cells by using an Epstein-Barr virus shuttle system. Mol Cell Biol 1987; 7: 379–387.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Rio D, Clark S, Tjian R . A mammalian host-vector system that regulates expression and amplification of transfected genes by temperature induction. Science 1985; 227: 23–28.

    Article  CAS  PubMed  Google Scholar 

  26. Merten OW, Charrier S, Laroudie N, Fauchille S, Dugue C, Jenny C et al. Large-scale manufacture and characterization of a lentiviral vector produced for clinical ex vivo gene therapy application. Hum Gene Ther 2011; 22: 343–356.

    Article  CAS  PubMed  Google Scholar 

  27. Verhoeyen E, Hauser H, Wirth D . Evaluation of retroviral vector design in defined chromosomal loci by Flp-mediated cassette replacement. Hum Gene Ther 2001; 12: 933–944.

    Article  CAS  PubMed  Google Scholar 

  28. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D et al. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998; 72: 8463–8471.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Cosset FL, Takeuchi Y, Battini JL, Weiss RA, Collins MK . High-titer packaging cells producing recombinant retroviruses resistant to human serum. J Virol 1995; 69: 7430–7436.

    CAS  PubMed  PubMed Central  Google Scholar 

  30. Bodin L, Beaune PH, Loriot MA . Determination of cytochrome P450 2D6 (CYP2D6) gene copy number by real-time quantitative PCR. J Biomed Biotechnol 2005; 2005: 248–253.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Rodrigues AF, Amaral AI, Verissimo V, Alves PM, Coroadinha AS . Adaptation of retrovirus producer cells to serum deprivation: Implications in lipid biosynthesis and vector production. Biotechnol Bioeng 2012; 109: 1269–1279.

    Article  CAS  PubMed  Google Scholar 

  32. Rodrigues AF, Carmo M, Alves PM, Coroadinha AS . Retroviral vector production under serum deprivation: the role of lipids. Biotechnol Bioeng 2009; 104: 1171–1181.

    Article  CAS  PubMed  Google Scholar 

  33. Carmo M, Peixoto C, Coroadinha AS, Alves PM, Cruz PE, Carrondo MJ . Quantitation of MLV-based retroviral vectors using real-time RT-PCR. J Virol Methods 2004; 119: 115–119.

    Article  CAS  PubMed  Google Scholar 

  34. Wand MP, Jones MC . Kernel Smoothing. Chapman and Hall/CRC: Boca Raton, FL, USA: Boca Raton, FL, USA, 1995.

    Book  Google Scholar 

Download references

Acknowledgements

We acknowledge Drs Catarina Duarte and Teresa Serra from Nutraceuticals and Delivery Laboratory, iBET, for access to the spectrofluorometer. We also acknowledge Fundação para a Ciência e a Tecnologia (FCT), Portugal, for financial support PTDC/EBB-BIO/118621/2010 and PTDC/EBB-BIO/118615/2010. ASF-O, MRG and HAT received PhD grants from FCT (SFRH/BD/97002/2013, SFRH/BD/90685/2012 and SFRH/BD/79022/2011, respectively).

Author information

Authors and Affiliations

  1. Instituto de Biologia Experimental e Tecnológica (iBET), Oeiras, Portugal

    A F Rodrigues, A S Formas-Oliveira, M R Guerreiro, H A Tomás, P M Alves & A S Coroadinha

  2. Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal

    A F Rodrigues, A S Formas-Oliveira, M R Guerreiro, H A Tomás, P M Alves & A S Coroadinha

Authors
  1. A F Rodrigues
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A S Formas-Oliveira
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M R Guerreiro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H A Tomás
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P M Alves
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A S Coroadinha
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A S Coroadinha.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies this paper on Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Rodrigues, A., Formas-Oliveira, A., Guerreiro, M. et al. Single-step cloning-screening method: a new tool for developing and studying high-titer viral vector producer cells. Gene Ther 22, 685–695 (2015). https://doi.org/10.1038/gt.2015.44

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2015.44

This article is cited by

Search

Advanced search

Quick links